BIOMAT Database Logo BIOMAT Database Logo

Hepatic metabolism in severe falciparum malaria: caffeine clearance study. 1994

P Wilairatana, and S Looareesuwan, and S Vanijanonta, and P Charoenlarp, and S Wittayalertpanya
Hospital for Tropical Diseases, Faculty of Tropical Medicine, Mahidol University, Bangkok, Thailand.

Falciparum malaria is known to cause abnormalities in the liver. Hepatic metabolism in patients with falciparum was studied by caffeine clearance and the results were related to the severity of the disease. Caffeine (3.5 mg/kg) was administered orally to patients with severe (N = 10) or uncomplicated (N = 9) falciparum malaria. The plasma clearances during illness averaged 0.67 +/- 0.27 ml/min kg for the severe cases and 0.98 +/- 0.36 ml/min kg for the uncomplicated cases (P < 0.05). In the severe patients, clearances during illness (0.67 +/- 0.27 ml/min kg) were less than those in convalescence (2.15 +/- 0.91 ml/min kg) (P < 0.0001). However, in the uncomplicated cases, the clearances during illness and in convalescence were similar (P > 0.05) and clearance rates in convalescence were similar for the severe and uncomplicated cases (P > 0.05). Hepatic microsomal metabolism is apparently slow in severe falciparum malaria but reverts to normal in convalescence. Liver metabolic function does not appear to be significantly affected in uncomplicated malaria.

UI MeSH Term Description Entries
D008099 Liver A large lobed glandular organ in the abdomen of vertebrates that is responsible for detoxification, metabolism, synthesis and storage of various substances. Livers
D008297 Male Males
D002110 Caffeine A methylxanthine naturally occurring in some beverages and also used as a pharmacological agent. Caffeine's most notable pharmacological effect is as a central nervous system stimulant, increasing alertness and producing agitation. It also relaxes SMOOTH MUSCLE, stimulates CARDIAC MUSCLE, stimulates DIURESIS, and appears to be useful in the treatment of some types of headache. Several cellular actions of caffeine have been observed, but it is not entirely clear how each contributes to its pharmacological profile. Among the most important are inhibition of cyclic nucleotide PHOSPHODIESTERASES, antagonism of ADENOSINE RECEPTORS, and modulation of intracellular calcium handling. 1,3,7-Trimethylxanthine,Caffedrine,Coffeinum N,Coffeinum Purrum,Dexitac,Durvitan,No Doz,Percoffedrinol N,Percutaféine,Quick-Pep,Vivarin,Quick Pep,QuickPep
D003289 Convalescence The period of recovery following an illness. Convalescences
D006207 Half-Life The time it takes for a substance (drug, radioactive nuclide, or other) to lose half of its pharmacologic, physiologic, or radiologic activity. Halflife,Half Life,Half-Lifes,Halflifes
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000208 Acute Disease Disease having a short and relatively severe course. Acute Diseases,Disease, Acute,Diseases, Acute
D000293 Adolescent A person 13 to 18 years of age. Adolescence,Youth,Adolescents,Adolescents, Female,Adolescents, Male,Teenagers,Teens,Adolescent, Female,Adolescent, Male,Female Adolescent,Female Adolescents,Male Adolescent,Male Adolescents,Teen,Teenager,Youths
D000328 Adult A person having attained full growth or maturity. Adults are of 19 through 44 years of age. For a person between 19 and 24 years of age, YOUNG ADULT is available. Adults
D016778 Malaria, Falciparum Malaria caused by PLASMODIUM FALCIPARUM. This is the severest form of malaria and is associated with the highest levels of parasites in the blood. This disease is characterized by irregularly recurring febrile paroxysms that in extreme cases occur with acute cerebral, renal, or gastrointestinal manifestations. Plasmodium falciparum Malaria,Malaria, Plasmodium falciparum

Related Publications

P Wilairatana, and S Looareesuwan, and S Vanijanonta, and P Charoenlarp, and S Wittayalertpanya
Hepatic blood flow and metabolism in severe falciparum malaria: clearance of intravenously administered galactose.
January 1992, Clinical science (London, England : 1979),
P Wilairatana, and S Looareesuwan, and S Vanijanonta, and P Charoenlarp, and S Wittayalertpanya
Glycerol metabolism in severe falciparum malaria.
July 1994, Metabolism: clinical and experimental,
P Wilairatana, and S Looareesuwan, and S Vanijanonta, and P Charoenlarp, and S Wittayalertpanya
Severe hepatic dysfunction associated with falciparum malaria.
March 2001, The Southeast Asian journal of tropical medicine and public health,
P Wilairatana, and S Looareesuwan, and S Vanijanonta, and P Charoenlarp, and S Wittayalertpanya
Severe falciparum malaria simulating fulminant hepatic failure.
March 2005, Mayo Clinic proceedings,
P Wilairatana, and S Looareesuwan, and S Vanijanonta, and P Charoenlarp, and S Wittayalertpanya
Slow Clearance of Plasmodium falciparum in Severe Pediatric Malaria, Uganda, 2011-2013.
July 2015, Emerging infectious diseases,
P Wilairatana, and S Looareesuwan, and S Vanijanonta, and P Charoenlarp, and S Wittayalertpanya
Severe falciparum malaria.
February 2004, Indian journal of pediatrics,
P Wilairatana, and S Looareesuwan, and S Vanijanonta, and P Charoenlarp, and S Wittayalertpanya
Severe falciparum malaria.
September 1986, The New Zealand medical journal,
P Wilairatana, and S Looareesuwan, and S Vanijanonta, and P Charoenlarp, and S Wittayalertpanya
Severe falciparum malaria.
July 1987, CMAJ : Canadian Medical Association journal = journal de l'Association medicale canadienne,
P Wilairatana, and S Looareesuwan, and S Vanijanonta, and P Charoenlarp, and S Wittayalertpanya
Reduced hepatic blood flow and intestinal malabsorption in severe falciparum malaria.
May 1989, The American journal of tropical medicine and hygiene,
P Wilairatana, and S Looareesuwan, and S Vanijanonta, and P Charoenlarp, and S Wittayalertpanya
Hepatic dysfunction in falciparum malaria.
August 1991, JPMA. The Journal of the Pakistan Medical Association,
Copied contents to your clipboard!